Yaron Naos
2021
In 2021, Yaron Naos earned a total compensation of $505.3K as Senior Vice President, Operations at Protalix BioTherapeutics.
Compensation breakdown
| Option Awards | $127,291 |
|---|---|
| Salary | $246,716 |
| Other | $131,280 |
| Total | $505,287 |
Naos received $246.7K in salary, accounting for 49% of the total pay in 2021.
Naos also received $127.3K in option awards and $131.3K in other compensation.
Rankings
In 2021, Yaron Naos' compensation ranked 10,706th out of 12,415 executives tracked by ExecPay. In other words, Naos earned more than 13.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,706 out of 12,415 | 14th |
Division Manufacturing | 4,725 out of 5,508 | 14th |
Major group Chemicals And Allied Products | 2,121 out of 2,378 | 11th |
Industry group Drugs | 1,884 out of 2,099 | 10th |
Industry Biological Products, Except Diagnostic Substances | 414 out of 449 | 8th |
Source: SEC filing on May 18, 2023.
Naos' colleagues
We found three more compensation records of executives who worked with Yaron Naos at Protalix BioTherapeutics in 2021.
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020
Protalix BioTherapeutics CEO Moshe Manor's 2018 pay falls 23% to $718K
April 12, 2019